Few new drugs deserve expedited regulatory treatment

Detalles Bibliográficos
Autor principal: Darrow, Jonathan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Expedited FDA Approval
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390900/
https://www.ncbi.nlm.nih.gov/pubmed/33908278
http://dx.doi.org/10.18553/jmcp.2021.27.5.685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390900/
https://www.ncbi.nlm.nih.gov/pubmed/33908278
http://dx.doi.org/10.18553/jmcp.2021.27.5.685

Ejemplares similares